PHAXIAM Therapeutics

Phaxiam therapeutics email format

Verified email-pattern data for Phaxiam Therapeutics is currently limited. You can still use the company insights and contact sections below.
PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.

Company Details

Employees
72
Founded
-
Address
60 Avenue Rockefeller, Bâtiment Bioserra,france
Industry
Biotechnology
HQ
LYON, Rhône-Alpes
Looking for a particular PHAXIAM Therapeutics employee's phone or email?

Phaxiam Therapeutics Questions

Top PHAXIAM Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant